Co-Authors
This is a "connection" page, showing publications co-authored by Kevin Winthrop and J Curtis.
Connection Strength
1.812
-
SARS CoV-2 infection among patients using immunomodulatory therapies. Ann Rheum Dis. 2021 02; 80(2):269-271.
Score: 0.224
-
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019 07; 54(1).
Score: 0.208
-
Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014. Chest. 2018 12; 154(6):1311-1320.
Score: 0.195
-
Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment. Arthritis Res Ther. 2017 Dec 15; 19(1):276.
Score: 0.187
-
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. Arthritis Rheumatol. 2017 10; 69(10):1960-1968.
Score: 0.183
-
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017 12; 152(6):1120-1127.
Score: 0.179
-
Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases. J Rheumatol. 2017 07; 44(7):1083-1087.
Score: 0.177
-
Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents. J Psoriasis Psoriatic Arthritis. 2016; 1(3):128-137.
Score: 0.163
-
Reply: To PMID 25201241. Arthritis Care Res (Hoboken). 2015 Jul; 67(7):1041-2.
Score: 0.157
-
Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World. J Manag Care Spec Pharm. 2019 Jun; 25(6):697-704.
Score: 0.052
-
Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection. J Rheumatol. 2017 05; 44(5):565-570.
Score: 0.044
-
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis. 2017 Jul; 76(7):1253-1262.
Score: 0.044